α-Synuclein BAC transgenic mice as a model for Parkinson's disease manifested decreased anxiety-like behavior and hyperlocomotion

[1]  P. Spano,et al.  Redistribution of DAT/α-Synuclein Complexes Visualized by “In Situ” Proximity Ligation Assay in Transgenic Mice Modelling Early Parkinson's Disease , 2011, PloS one.

[2]  G. Torres,et al.  Proteins interacting with monoamine transporters: current state and future challenges. , 2011, Biochemistry.

[3]  A. Sidhu,et al.  Synuclein modulation of monoamine transporters , 2011, FEBS letters.

[4]  H. Tanila,et al.  Decreased reuptake of dopamine in the dorsal striatum in the absence of alpha-synuclein , 2011, Brain Research.

[5]  H. Bönisch,et al.  Depression and antidepressants: insights from knockout of dopamine, serotonin or noradrenaline re-uptake transporters. , 2011, Pharmacology & therapeutics.

[6]  A. Sidhu,et al.  Mice expressing the A53T mutant form of human alpha‐synuclein exhibit hyperactivity and reduced anxiety‐like behavior , 2010, Journal of neuroscience research.

[7]  Lourens J P Nonkes,et al.  Conserved role for the serotonin transporter gene in rat and mouse neurobehavioral endophenotypes , 2010, Neuroscience & Biobehavioral Reviews.

[8]  R. Nussbaum,et al.  Extensive enteric nervous system abnormalities in mice transgenic for artificial chromosomes containing Parkinson disease-associated alpha-synuclein gene mutations precede central nervous system changes. , 2010, Human molecular genetics.

[9]  Yusuke Nakamura,et al.  Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease , 2009, Nature Genetics.

[10]  K. Channon,et al.  The effect of α‐synuclein knockdown on MPP+ toxicity in models of human neurons , 2008, The European journal of neuroscience.

[11]  P. Spano,et al.  Alpha‐synuclein aggregation and cell death triggered by energy deprivation and dopamine overload are counteracted by D2/D3 receptor activation , 2008, Journal of neurochemistry.

[12]  D. Murphy,et al.  Locomotory patterns, spatiotemporal organization of exploration and spatial memory in serotonin transporter knockout mice , 2007, Brain Research.

[13]  Sanbing Shen,et al.  Increased Expression of the 5-HT Transporter Confers a Low- Anxiety Phenotype Linked to Decreased 5-HT Transmission , 2006, The Journal of Neuroscience.

[14]  J. Langston,et al.  The parkinson's complex: Parkinsonism is just the tip of the iceberg , 2006, Annals of neurology.

[15]  H. Inoko,et al.  Multiple candidate gene analysis identifies alpha-synuclein as a susceptibility gene for sporadic Parkinson's disease. , 2006, Human molecular genetics.

[16]  Erica L. Unger,et al.  Locomotor hyperactivity and alterations in dopamine neurotransmission are associated with overexpression of A53T mutant human α-synuclein in mice , 2006, Neurobiology of Disease.

[17]  R. Rodriguiz,et al.  Novelty Seeking and Stereotypic Activation of Behavior in Mice with Disruption of the Dat1 Gene , 2005, Neuropsychopharmacology.

[18]  A Dürr,et al.  Causal relation between α-synuclein locus duplication as a cause of familial Parkinson's disease , 2004, The Lancet.

[19]  Philippe Amouyel,et al.  α-synuclein locus duplication as a cause of familial Parkinson's disease , 2004, The Lancet.

[20]  Janel O. Johnson,et al.  α-Synuclein Locus Triplication Causes Parkinson's Disease , 2003, Science.

[21]  Nancy A. Jenkins,et al.  Human α-synuclein-harboring familial Parkinson's disease-linked Ala-53 → Thr mutation causes neurodegenerative disease with α-synuclein aggregation in transgenic mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[22]  J. Trojanowski,et al.  Neuronal α-Synucleinopathy with Severe Movement Disorder in Mice Expressing A53T Human α-Synuclein , 2002, Neuron.

[23]  Howard J. Federoff,et al.  Behavioral and Neurochemical Effects of Wild-Type and Mutated Human α-Synuclein in Transgenic Mice , 2002, Experimental Neurology.

[24]  L. Mucke,et al.  Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. , 2000, Science.

[25]  M. L. Schmidt,et al.  α-Synuclein in Lewy bodies , 1997, Nature.